SC dismisses plea against GlaxoSmithKline pharma for deficiency in service
A bench of Justices A S Bopanna and Prashant Kumar Mishra said the drug is made available in the market after certification and nothing has been placed on record to indicate that this is a drug which was available "of the shelf", without prescription.